
Groundbreaking Ozempic study – Conducted in Part at AdventHealth – Could Increase Access for People with Chronic Kidney Disease
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.